Literature DB >> 7074817

Chronic urticaria and angioedema.

P Small, D Barrett, N Biskin, E Champlin.   

Abstract

Of 231 patients evaluated for chronic urticaria and angioedema (CUA), 192 were diagnosed as having an idiopathic condition. The roles of serum IgE, complement (CH50), and immune complexes (IC) were investigated in 112 patients with idiopathic CUA. Immediate skin tests were not helpful, but total IgE was elevated in 13%, equally divided between dermographic (D) and non-dermographic (ND) patients. Depressed haemolytic complement (CH50) was noted in 10% of CUA, all of whom were D. Serum IC were elevated in 38% equally divided between D and ND patients. There was no relationship between depressed CH50 and elevated IC. Skin biopsies, evaluated by both light and immunofluorescent techniques, were negative for all specimens tested. The pathophysiology of idiopathic CUA is multifactorial, with a variety of immunological mechanisms involving serum IgE, CH50, and IC. . The relationship between depressed CH50 and dermographism was noted but unexplained by serum or tissue studies.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7074817     DOI: 10.1111/j.1365-2222.1982.tb01631.x

Source DB:  PubMed          Journal:  Clin Allergy        ISSN: 0009-9090


  3 in total

1.  [Chronic urticaria. Prevalence, course, prognostic factors and impact].

Authors:  K Weller; S Altrichter; E Ardelean; K Krause; M Magerl; M Metz; F Siebenhaar; M Maurer
Journal:  Hautarzt       Date:  2010-09       Impact factor: 0.751

2.  Astemizole, a potent histamine H1-receptor antagonist: effect in allergic rhinoconjunctivitis, on antigen and histamine induced skin weal responses and relationship to serum levels.

Authors:  P H Howarth; M B Emanuel; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

3.  Comparative trial of two non-sedative H1 antihistamines, terfenadine and astemizole, for hay fever.

Authors:  P H Howarth; S T Holgate
Journal:  Thorax       Date:  1984-09       Impact factor: 9.139

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.